U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807059) titled 'A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment' on Aug. 17.
Brief Summary: This study aims to evaluate the pharmacokinetic effects of a single dose of HRS-4729 injection in participants with mild, moderate, and severe renal impairment, with 8 participants enrolled in each renal impairment group and 8 healthy participants.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Overweight/Obesity
Metabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)
Type 2 Diabetes Mellitus
Intervention:
DRUG: HRS-4729
Each subject...